Understanding inflammation's role in Parkinson's disease
Mechanisms and indicators of inflammasome signaling in Parkinson’s disease
This study is looking at how inflammation in the immune system might play a role in Parkinson's disease, especially for people who have been around pesticides, and it hopes to find new ways to understand and treat the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dartmouth College NIH-funded |
| Lab location | 1 site (Hanover, United States) |
| Project ID | NIH-10687222 on NIH RePORTER |
What this research studies
This research investigates how inflammation in the immune system contributes to Parkinson's disease, particularly in individuals exposed to pesticides. By studying both mice and patients, the team aims to identify specific inflammatory mechanisms and indicators that may be linked to military occupations and environmental toxins. The research focuses on the NLRP3 inflammasome, a key player in the inflammatory response, to understand its role in neurodegeneration. The findings could lead to better understanding and potential treatments for Parkinson's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with Parkinson's disease, particularly those with a history of pesticide exposure or military service.
Not a fit: Patients without Parkinson's disease or those not exposed to relevant environmental toxins may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating Parkinson's disease by targeting inflammation.
How similar studies have performed: Previous research has shown promising results in understanding the role of inflammation in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Hanover, United States
- Dartmouth College — Hanover, United States (Active)
Researchers
- Principal investigator: Havrda, Matthew Charles — Dartmouth College
- Study coordinator: Havrda, Matthew Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.